Trial description:
A Phase 2, Multicenter Study to Assess the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients with Metastatic Melanoma
Contact name:
Dr Pippa Corrie
Trial start date:
Wednesday, June 27, 2018
Trial end date:
Monday, September 3, 2018
Trial tumour type:
Skin & melanoma
Show on Radiotherapy:
No
